Pfizer & BioNTech phase 3 COVID-19 vaccine trials resume in SA
Thu Oct 01 2020 | 11:18:03 GMT+0000 (Coordinated Universal Time)
Pfizer and BioNTech have started its enrolment of participants in South Africa for its phase 3 COVID-19 vaccine trials.
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.